Related Experiment Video
Updated: Sep 25, 2025

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
Published on: August 25, 2017
Visceral Kaposi's Sarcoma as a Presentation in a Newly Diagnosed HIV-Infected Man: A Case Report
Zeinab El Mawla1, Hiba Ghannoum2, Michelle Saliba3
1Internal Medicine, Lebanese University Faculty of Medical Sciences, Beirut, LBN.
Abstract:
Kaposi's sarcoma is an angioproliferative malignancy due to human herpesvirus-8 and is associated with immunosuppression. Although most cases are cutaneous and resolve with treatment of the underlying condition, few cases present with organ involvement and have a fulminant course. We present a case of a 24-year-old sexually active man who presented with fulminant visceral Kaposi's sarcoma, without cutaneous involvement. He presented with anasarca, high fever, hypoalbuminemia, and anemia on day five of antiretroviral therapy (ART). There was clinical improvement after the first dose of liposomal doxorubicin. However, given that he developed refractory pancytopenia, with disease relapse by the third week, he received a second dose of doxorubicin, with no clinical improvement, and the patient died with multi-organ dysfunction on day 22 of presentation. The main treatment is liposomal doxorubicin with ART, and the disease is typically associated with a poor prognosis.
Related Concept Videos
Sexually Transmitted Infections
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

